Itochu in Australian biotech pact

3 April 2001

Itochu Corp has entered into an alliance with three Australian researchinstitutes, with the aim of marketing their biotechnology products in Japan, according to the Nihon Keizai Shimbun. The three institutes include two state-affiliated groups - the Commonwealth Scientific and Industrial Research Organization and the Australian Institute of Marine Science - as well as the Institute for Molecular Bioscience.

Principally, Itochu will market biotechnology software for genetic diagnosis and protein analysis, developed by the CSIRO and the IMB, to Japanese pharmaceutical firms. It is the first time that Itochu has linked up with a foreign institute in the biotechnology field.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight